Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma
New Findings on Immune System Control of Eosinophils Presented
March 31st, 2000
Magainin Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, announced the presentation of preclinical data highlighting the important role of interleukin-9 (IL-9) in controlling eosinophils, one of the critical inflammatory cells involved in the asthmatic response, at the American Academy of Allergy, Asthma and Immunology (AAAAI) Meeting held in San Diego, California, during March 2000. Researchers from McGill University of Montreal, Canada, presented the study conducted in collaboration with Magainin, "Interleukin-9 Enhances IL5 Receptor Expression, Differentiation, and Survival of Human Eosinophils." The findings demonstrate that IL-9 potentiates eosinophil...
Source: Drug Week (2000-03-31)
|
